The Three Receptor Tyrosine Kinases c-KIT, VEGFR2 and PDGFRα, Closely Spaced at 4q12, Show Increased Protein Expression in Triple-Negative Breast Cancer
出版年份 2014 全文链接
标题
The Three Receptor Tyrosine Kinases c-KIT, VEGFR2 and PDGFRα, Closely Spaced at 4q12, Show Increased Protein Expression in Triple-Negative Breast Cancer
作者
关键词
Breast cancer, Protein expression, Cancer treatment, Immunohistochemistry techniques, Prognosis, Biopsy, Cancer detection and diagnosis, Cell staining
出版物
PLoS One
Volume 9, Issue 7, Pages e102176
出版商
Public Library of Science (PLoS)
发表日期
2014-07-16
DOI
10.1371/journal.pone.0102176
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years’ follow-up
- (2013) Anna-Karin Falck et al. BREAST CANCER RESEARCH AND TREATMENT
- c-Kit expression as a prognostic molecular marker in patients with basal-like breast cancer
- (2013) S. Kashiwagi et al. BRITISH JOURNAL OF SURGERY
- Protein Kinase C α Is a Central Signaling Node and Therapeutic Target for Breast Cancer Stem Cells
- (2013) Wai Leong Tam et al. CANCER CELL
- Comparison of basal-like triple-negative breast cancer defined by morphology, immunohistochemistry and transcriptional profiles
- (2013) Patrycja Gazinska et al. MODERN PATHOLOGY
- Distinct Phenotypic Differences Associated with Differential Amplification of Receptor Tyrosine Kinase Genes at 4q12 in Glioblastoma
- (2013) Anna Burford et al. PLoS One
- Analysis of and prognostic information from disseminated tumour cells in bone marrow in primary breast cancer: a prospective observational study
- (2012) Anna-Karin Falck et al. BMC CANCER
- Inference of the Basal Epithelial Phenotype in Breast Carcinoma from Differential Marker Expression, Using Tissue Microarrays in Triple Negative Breast Cancer and Women Younger than 35
- (2012) Aziza Nassar et al. Breast Journal
- Expression of vascular endothelial growth factor and vascular endothelial growth factor receptors 1 and 2 in invasive breast carcinoma: prognostic significance and relationship with markers for aggressiveness
- (2012) Hari Prasad Dhakal et al. HISTOPATHOLOGY
- Neoadjuvant Chemotherapy and Bevacizumab for HER2-Negative Breast Cancer
- (2012) Gunter von Minckwitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
- (2011) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Twist1-Induced Invadopodia Formation Promotes Tumor Metastasis
- (2011) Mark A. Eckert et al. CANCER CELL
- Increased gene copy number of KIT and VEGFR2 at 4q12 in primary breast cancer is related to an aggressive phenotype and impaired prognosis
- (2011) Ida Johansson et al. GENES CHROMOSOMES & CANCER
- Targeted therapies for breast cancer
- (2011) Michaela J. Higgins et al. JOURNAL OF CLINICAL INVESTIGATION
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Gene expression profiling in breast cancer: classification, prognostication, and prediction
- (2011) Jorge S Reis-Filho et al. LANCET
- Epidermal growth factor receptor and vascular endothelial growth factor receptor 2 are specific biomarkers in triple-negative breast cancer. Results from a controlled randomized trial with long-term follow-up
- (2010) Lisa Rydén et al. BREAST CANCER RESEARCH AND TREATMENT
- Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer
- (2010) Carlos H. Barrios et al. BREAST CANCER RESEARCH AND TREATMENT
- Characteristics of triple-negative breast cancer
- (2010) Tim C. de Ruijter et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Minireview: Basal-Like Breast Cancer: From Molecular Profiles to Targeted Therapies
- (2010) Daniel J. Toft et al. MOLECULAR ENDOCRINOLOGY
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- The 4q12 Amplicon in Malignant Peripheral Nerve Sheath Tumors: Consequences on Gene Expression and Implications for Sunitinib Treatment
- (2010) Jan Zietsch et al. PLoS One
- An exploratory study of sunitinib plus paclitaxel as first-line treatment for patients with advanced breast cancer
- (2009) M. Kozloff et al. ANNALS OF ONCOLOGY
- Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes
- (2009) E. A. Rakha et al. CLINICAL CANCER RESEARCH
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
- (2009) Maggie C. U. Cheang et al. JNCI-Journal of the National Cancer Institute
- Epithelial-Mesenchymal Transition in Breast Cancer Relates to the Basal-like Phenotype
- (2008) D. Sarrio et al. CANCER RESEARCH
- Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype
- (2008) M. C.U. Cheang et al. CLINICAL CANCER RESEARCH
- How basal are triple-negative breast cancers?
- (2008) François Bertucci et al. INTERNATIONAL JOURNAL OF CANCER
- Phase II Study of Sunitinib Malate, an Oral Multitargeted Tyrosine Kinase Inhibitor, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
- (2008) Harold J. Burstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Cutaneous T-cell lymphoma-associated lung cancers show chromosomal aberrations differing from primary lung cancer
- (2007) Sonja Hahtola et al. GENES CHROMOSOMES & CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search